ChatGPT v4 outperforming v3.5 on cancer treatment recommendations in quality, clinical guideline, and expert opinion concordance.
ChatGPT v4 在癌症治療建議的質量、臨床指導和專家意見一致性方面超越 v3.5。
Digit Health 2024-08-16
Exploring the landscape of AI-assisted decision-making in head and neck cancer treatment: a comparative analysis of NCCN guidelines and ChatGPT responses.
探索AI輔助決策在頭頸癌治療中的應用:NCCN指南與ChatGPT回應的比較分析。
Eur Arch Otorhinolaryngol 2024-04-02
Enhanced Artificial Intelligence Strategies in Renal Oncology: Iterative Optimization and Comparative Analysis of GPT 3.5 Versus 4.0.
腎臟腫瘤學中增強人工智慧策略:GPT 3.5與4.0的迭代優化和比較分析。
Ann Surg Oncol 2024-03-13
Chat-GPT on brain tumors: An examination of Artificial Intelligence/Machine Learning's ability to provide diagnoses and treatment plans for example neuro-oncology cases.
談論腦腫瘤:人工智慧/機器學習在提供診斷和治療計劃方面的能力,以神經腫瘤學案例為例。
Clin Neurol Neurosurg 2024-04-02
Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model.
人工智慧大型語言模型提供的攝護腺癌預防和篩檢建議的適當性。
Int Urol Nephrol 2024-04-02
From Bytes to Best Practices: Tracing ChatGPT-3.5's Evolution and Alignment With the National Comprehensive Cancer Network® Guidelines in Pancreatic Adenocarcinoma Management.
從位元組到最佳實踐:追蹤 ChatGPT-3.5 的演進,並與國家綜合癌症網絡指南在胰腺腺癌管理中的一致性。
Am Surg 2024-04-26
ChatGPT compared to national guidelines for management of ovarian cancer: Did ChatGPT get it right? - A Memorial Sloan Kettering Cancer Center Team Ovary study.
ChatGPT 與卵巢癌管理的國家指導方針比較:ChatGPT 是否正確?- 來自紀念斯隆凱特琳癌症中心的 Team Ovary 研究。
Gynecol Oncol 2024-07-23
Evaluating the Efficacy of ChatGPT as a Patient Education Tool in Prostate Cancer: Multimetric Assessment.
評估 ChatGPT 作為前列腺癌患者教育工具的有效性:多指標評估。
J Med Internet Res 2024-08-14
Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for recurrent/metastatic head and neck cancer cases - the first study on ChatGPT 4o and a comparison to ChatGPT 4.0.
評估先進人工智慧在多學科腫瘤委員會決策中對於復發/轉移性頭頸癌病例的角色 - 首次針對 ChatGPT 4.0 的研究及與 ChatGPT 4.0 的比較。
Front Oncol 2024-09-20